611 W. Union Street
Benson, AZ 85602
(520) 586-0800

Health Choice Integrated Care crisis Line

NurseWise 24-Hour Crisis Line


611 W. Union Street
Benson, AZ 85602
(520) 586-0800

NurseWise 24-Hr Crisis Line


powered by centersite dot net

Getting Started
Here are some forms to get started. These can be printed and brought with you so that you can pre-fill out some known info ahead of time. More...

Post-Traumatic Stress Disorder
Basic Information
Introduction to Trauma and Stressor-Related DisordersSigns and Symptoms of Trauma and Stressor-Related DisordersDiagnostic Descriptions of Trauma and Stressor-Related DisordersWhat Causes the Symptoms of Trauma-Related Disorders? Treatment of Trauma, PTSD, Abuse and Other Stressor-Related Disorders Conclusion, Resources and ReferencesDealing with the Effects of Trauma - A Self-Help Guide
More InformationLatest NewsQuestions and AnswersLinksBook Reviews
Related Topics

Anxiety Disorders
Depression: Depression & Related Conditions
Addictions: Alcohol and Substance Abuse
Dissociative Disorders

Non-Invasive Neurotechnology May Help Ease PTSD Symptoms

HealthDay News
Updated: Apr 19th 2017

new article illustration

WEDNESDAY, April 19, 2017 (HealthDay News) -- Technology using a patient's own brainwaves might offer hope against tough-to-treat posttraumatic stress disorder (PTSD), according to a study published online April 19 in BMC Psychiatry.

The new study was led by researchers at the Wake Forest Baptist Medical Center in Winston-Salem, N.C. It involved 18 patients who completed an average of 16 successive, daily sessions of noninvasive closed-loop acoustic stimulation brainwave technology. During the sessions, the patients' brain activity was monitored and certain brain frequencies were translated into acoustic tones that were then relayed back to the patients via earbuds.

"It's as if the brain can look at itself in an acoustic mirror, recalibrate its patterns towards improved balance and reduced hyperarousal, and can relax," lead author Charles Tegeler, M.D., professor of neurology at the Wake Forest School of Medicine, said in a school news release.

The researchers found that after the sessions, 89 percent of the patients reported clinically meaningful decreases in PTSD symptoms. There were no adverse events reported.

Two authors are employees and shareholders at Brain State Technologies, developers of the allostatic neurotechnology evaluated in the study.

Abstract/Full Text